Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06409247 · ClinicalTrials.gov registry record · NA
iExposure Intervention for Social Anxiety
A NA study of Social Anxiety, sponsored by Palo Alto University.
- Active
- Registry status
- NA
- Development phase
- 390
- Enrollment target
- 1
- Study location
NCT06409247: Active NA study of Social Anxiety, sponsored by Palo Alto University.
NCT06409247 is a NA study of Social Anxiety that is active but no longer recruiting, run by Palo Alto University. The registered enrollment target is 390 participants, below the 502-participant average among 3 other Social Anxiety trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06409247, a NA study of Social Anxiety, is active but no longer recruiting, sponsored by Palo Alto University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 390 participants
- Enrollment target
- 1
- Study location
Study Summary
Social anxiety (SA) is a highly prevalent mental health concern, thought to disproportionately affect youth with recent international estimates of more than 30% of individuals reporting clinically elevated symptoms. Despite the prevalence of SA, as few as one in five individuals receive care, due to limited access to evidence-based treatments. Additionally there has been a notable increase in social anxiety since the start of the COVID-19 pandemic. This proposal will use iExposure to develop a personalized mechanism-focused approach to optimizing treatment response for individuals with social anxiety by testing standard iExposure against two augmentations that incorporate distinct attention mechanisms (attention guidance and attention control).
Primary Outcome
The Liebowitz Social Anxiety Scale Self Report Version is a 48-item self-report measure of fear and avoidance concerning social interactions and performance situations (e.g., telephoning in public, talking to people in authority). The range of scores is 0-144; higher scores are worse.
Conditions Studied
Interventions
- BEHAVIORAL iExposure
- BEHAVIORAL iExposure plus attention guidance
- BEHAVIORAL iExposure plus attention control
Study Locations (1)
California
- Palo Alto University - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 390 participants |
| Start Date | 2024-07-01 |
| Est. Completion | 2026-03-30 |
| Phase | NA |
What the registry record for NCT06409247 still lists
NCT06409247 is an interventional study that assigns participants to a tested intervention. The registered 390 participants enrollment target is mid-sized for trials with a published cap, below the 502-participant average among 3 other Social Anxiety trials with a reported enrollment target (22% lower).
The record links to 1 condition, with Social Anxiety appearing as the primary indexed condition, and to 3 interventions - of which iExposure is the first listed.
NCT06409247 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06409247 about?
NCT06409247 is a clinical study titled "iExposure Intervention for Social Anxiety". Social anxiety (SA) is a highly prevalent mental health concern, thought to disproportionately affect youth with recent international estimates of more than 30% of individuals reporting clinically elevated symptoms. Despite the prevalence of SA, as few as one in five individuals receive care, due to...
What is the current status of trial NCT06409247?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 390 participants. The study started on 2024-07-01. Estimated completion is 2026-03-30.
What conditions does trial NCT06409247 study?
This clinical trial studies the following conditions: Social Anxiety.
What interventions are being tested in trial NCT06409247?
The interventions under investigation include: iExposure (BEHAVIORAL), iExposure plus attention guidance (BEHAVIORAL), iExposure plus attention control (BEHAVIORAL).
Who is sponsoring clinical trial NCT06409247?
This trial is sponsored by Palo Alto University, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06409247 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Social Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00397111 · 390 participants
Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders
- NCT05335928 · 390 participants · Phase 3
Abatacept in Immune Checkpoint Inhibitor Myocarditis
- NCT05445960 · 390 participants · NA
Correlation Between Intraoperative Tourniquet Use and Limb pH, Functional Measures and Patient-reported Outcomes After Ankle Fracture Surgery
- NCT05997615 · 390 participants · Phase 1
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI